These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 19346107
1. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Fenollar F, Rolain JM, Alric L, Papo T, Chauveheid MP, van de Beek D, Raoult D. Int J Antimicrob Agents; 2009 Sep; 34(3):255-9. PubMed ID: 19346107 [Abstract] [Full Text] [Related]
2. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene. Bakkali N, Fenollar F, Biswas S, Rolain JM, Raoult D. J Infect Dis; 2008 Jul 01; 198(1):101-8. PubMed ID: 18500934 [Abstract] [Full Text] [Related]
3. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. Lagier JC, Fenollar F, Lepidi H, Raoult D. J Antimicrob Chemother; 2010 Sep 01; 65(9):2005-12. PubMed ID: 20639526 [Abstract] [Full Text] [Related]
4. Ocular Whipple's disease: therapeutic strategy and long-term follow-up. Touitou V, Fenollar F, Cassoux N, Merle-Beral H, LeHoang P, Amoura Z, Drancourt M, Bodaghi B. Ophthalmology; 2012 Jul 01; 119(7):1465-9. PubMed ID: 22420960 [Abstract] [Full Text] [Related]
5. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. Feurle GE, Moos V, Bläker H, Loddenkemper C, Moter A, Stroux A, Marth T, Schneider T. J Infect; 2013 Mar 01; 66(3):263-70. PubMed ID: 23291038 [Abstract] [Full Text] [Related]
6. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review. Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomão DR, Walker RC. Transpl Infect Dis; 2008 Dec 01; 10(6):413-8. PubMed ID: 18564981 [Abstract] [Full Text] [Related]
7. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Fenollar F, Perreal C, Raoult D. Int J Antimicrob Agents; 2014 Apr 01; 43(4):388-90. PubMed ID: 24613421 [No Abstract] [Full Text] [Related]
8. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Feurle GE, Junga NS, Marth T. Gastroenterology; 2010 Feb 01; 138(2):478-86; quiz 11-2. PubMed ID: 19879276 [Abstract] [Full Text] [Related]
9. Treatment of classic Whipple's disease: from in vitro results to clinical outcome. Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. J Antimicrob Chemother; 2014 Jan 01; 69(1):219-27. PubMed ID: 23946319 [Abstract] [Full Text] [Related]
10. [Whipple's disease with normal duodenal histology and ankylosing spondylitis]. Ahmadi-Simab K, Schnitzler P. Dtsch Med Wochenschr; 2009 Jan 01; 134(4):127-30. PubMed ID: 19148854 [Abstract] [Full Text] [Related]
14. Endocarditis due to Tropheryma whipplei: rapid detection, limited genetic diversity, and long-term clinical outcome in a local experience. Escher R, Roth S, Droz S, Egli K, Altwegg M, Täuber MG. Clin Microbiol Infect; 2010 Aug 01; 16(8):1213-22. PubMed ID: 19732090 [Abstract] [Full Text] [Related]
15. Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazole. Lévy M, Poyart C, Lamarque D, Delchier JC. Am J Gastroenterol; 2000 Sep 01; 95(9):2390-1. PubMed ID: 11007254 [No Abstract] [Full Text] [Related]